The Chemours Company (NYSE:CC - Get Free Report) reached a new 52-week low on Tuesday after Barclays lowered their price target on the stock from $23.00 to $19.00. Barclays currently has an equal weight rating on the stock. Chemours traded as low as $14.94 and last traded at $15.39, with a volume of 1464175 shares trading hands. The stock had previously closed at $16.15.
Other equities analysts have also recently issued reports about the stock. The Goldman Sachs Group dropped their target price on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research report on Tuesday, January 7th. BMO Capital Markets cut their target price on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 19th. Morgan Stanley dropped their price target on Chemours from $25.00 to $22.00 and set an "equal weight" rating for the company in a research note on Monday, January 13th. Mizuho reduced their price objective on Chemours from $22.00 to $21.00 and set a "neutral" rating on the stock in a research report on Tuesday, January 7th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $23.11.
View Our Latest Analysis on CC
Hedge Funds Weigh In On Chemours
Hedge funds have recently bought and sold shares of the company. FMR LLC boosted its holdings in shares of Chemours by 3.5% during the 3rd quarter. FMR LLC now owns 18,142,202 shares of the specialty chemicals company's stock worth $368,650,000 after buying an additional 618,361 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Chemours by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 15,223,961 shares of the specialty chemicals company's stock valued at $257,285,000 after purchasing an additional 94,885 shares during the period. Ameriprise Financial Inc. boosted its position in shares of Chemours by 23.8% during the 4th quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock worth $73,907,000 after purchasing an additional 839,849 shares in the last quarter. Millennium Management LLC increased its position in Chemours by 44.6% in the 4th quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company's stock valued at $42,373,000 after buying an additional 773,537 shares in the last quarter. Finally, Geode Capital Management LLC raised its stake in Chemours by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 2,491,748 shares of the specialty chemicals company's stock worth $50,646,000 after buying an additional 28,803 shares during the period. Institutional investors own 76.26% of the company's stock.
Chemours Trading Down 1.6 %
The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The firm has a fifty day simple moving average of $17.86 and a 200-day simple moving average of $18.82. The firm has a market cap of $2.23 billion, a P/E ratio of 26.23 and a beta of 1.81.
Chemours (NYSE:CC - Get Free Report) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.37 billion. On average, equities research analysts expect that The Chemours Company will post 2.03 earnings per share for the current year.
Chemours Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 6.69%. The ex-dividend date of this dividend is Friday, February 28th. Chemours's dividend payout ratio is 175.44%.
About Chemours
(
Get Free Report)
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
See Also
Before you consider Chemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemours wasn't on the list.
While Chemours currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
